3 条结果 关键词:雄激素受体 ×

High-Content Screening Campaign to Identify Compounds That Inhibit or Disrupt Androgen Receptor-Transcriptional Intermediary Factor 2 Protein-Protein Interactions for the Treatment of Prostate Cancer.

Assay and drug development technologies 2018 Fancher AT, Hua Y, Camarco DP, Close DA 等 6 人

约20%前列腺癌(PCa)患者会进展为不可治愈的去势抵抗性前列腺癌(CRPC),雄激素受体(AR)共激活因子转录中介因子2(TIF2)过表达与不良预后相关。本研究将AR-TIF2蛋白-蛋白相互作用生物传感器(PPIB)高内容筛选(HCS)应用于143,535个化合物,筛选能抑制双氢睾酮(DHT)诱导的AR-TIF2相互作用形成或破坏...

Identification of d-seco modified steroid derivatives with affinity for estrogen receptor α and β isoforms using a non-transcriptional fluorescent cell assay in yeast.

Steroids 2018 Bekić SS, Marinović MA, Petri ET, Sakač MN 等 7 人

本文报道了一种在酿酒酵母中优化的非转录荧光细胞检测法,用于测定 D-seco 修饰甾体衍生物对雌激素受体 α、雌激素受体 β 或雄激素受体配体结合域的相对亲和力。将类固醇受体配体结合域与黄色荧光蛋白在酵母中融合表达;加入已知类固醇配体后,受体二聚化引起荧光共振能量转移,使荧光强度增加,从而可按剂量和时间依赖方式估计受体结合亲和力。利...

High Content Positional Biosensor Assay to Screen for Compounds that Prevent or Disrupt Androgen Receptor and Transcription Intermediary Factor 2 Protein-Protein Interactions.

Methods in molecular biology (Clifton, N.J.) 2018 Hua Y, Camarco DP, Strock CJ, Johnston PA

转录中介因子2(TIF2)是雄激素受体(AR)的关键共激活因子,参与去势抵抗性前列腺癌(CRPC)的发生与进展。本章报道了一种AR-TIF2蛋白-蛋白相互作用(PPI)生物传感器检测,用于筛选能够诱导AR-TIF2 PPI、抑制二氢睾酮(DHT)诱导的AR-TIF2 PPI形成或破坏已有AR-TIF2 PPI的小分子。该检测采用高内...